Dow Dorothy E, Mmbaga Blandina T, Gallis John A, Turner Elizabeth L, Gandhi Monica, Cunningham Coleen K, O'Donnell Karen E
Duke University Medical Center, Pediatrics, Infectious Diseases, Box 3499, Durham, NC, 27710, USA.
Duke Global Health Institute, Durham, NC, USA.
BMC Public Health. 2020 Sep 4;20(1):1358. doi: 10.1186/s12889-020-09380-3.
Increasing numbers of young people living with HIV (YPLWH) have unaddressed mental health challenges. Such challenges are associated with poor antiretroviral therapy (ART) adherence and high mortality. Few evidence-based mental health interventions exist to improve HIV outcomes among YPLWH.
This pilot group treatment trial individually randomized YPLWH from two clinical sites in Tanzania, evaluated acceptability, feasibility, and preliminary effectiveness of a mental health intervention, Sauti ya Vijana (SYV; The Voice of Youth), was compared to the local standard-of-care (SOC) for improving ART adherence and virologic suppression. Enrolled YPLWH were 12-24 years of age and responded to mental health and stigma questionnaires, self-reported adherence, objective adherence measures (ART concentration in hair), and HIV RNA at baseline and 6-months (post-intervention). Feasibility and acceptability were evaluated, and potential effectiveness was assessed by comparing outcomes between arms using mixed effects modeling.
Between June 2016 and July 2017, 128 YPLWH enrolled; 105 were randomized and 93 (55 in SYV) followed-up at 6-months and were thereby included in this analysis. Mean age was 18.1 years; 51% were female; and 84% were HIV-infected perinatally. Attendance to intervention sessions was 86%; 6-month follow-up was 88%, and fidelity to the protocol approached 100%. Exploratory analyses of effectiveness demonstrated self-reported adherence improved by 7.3 percentage points (95% CI: 2.2, 12.3); and the pooled standard deviation for all ART concentration values increased by 0.17 units (95% CI: - 0.52, 0.85) in the SYV arm compared to SOC. Virologic suppression rates (HIV RNA < 400 copies/mL) at baseline were 65% in both arms but increased to 75% in the SYV arm while staying the same in the SOC arm (RR 1.13; 95% CI: 0.94, 1.36).
YPLWH often have poor HIV outcomes, making interventions to improve outcomes in this population critical. This pilot trial of the Tanzania-based SYV intervention demonstrated trends towards improvement in ART adherence and virologic outcomes among YPLWH, supporting efforts to scale the intervention into a fully-powered effectiveness trial.
ClinicalTrials.gov Identifier: NCT02888288 . Registered August 9, 2016. Retrospectively registered as first participant enrolled June 16, 2016.
感染艾滋病毒的年轻人(YPLWH)数量不断增加,他们面临着未得到解决的心理健康挑战。这些挑战与抗逆转录病毒疗法(ART)依从性差和高死亡率相关。几乎没有基于证据的心理健康干预措施来改善YPLWH的艾滋病毒治疗结果。
这项试点小组治疗试验将来自坦桑尼亚两个临床地点的YPLWH进行个体随机分组,评估了一种心理健康干预措施“青年之声”(Sauti ya Vijana,SYV)的可接受性、可行性和初步有效性,并将其与当地标准护理(SOC)进行比较,以提高ART依从性和病毒学抑制。纳入的YPLWH年龄在12至24岁之间,他们对心理健康和耻辱感问卷、自我报告的依从性、客观依从性测量(头发中的ART浓度)以及基线和6个月(干预后)时的HIV RNA做出了回应。评估了可行性和可接受性,并通过使用混合效应模型比较两组之间的结果来评估潜在有效性。
在2016年6月至2017年7月期间,128名YPLWH入组;105名被随机分组,93名(SYV组55名)在6个月时接受了随访,因此被纳入本分析。平均年龄为18.1岁;51%为女性;84%为围产期感染艾滋病毒。干预课程的出勤率为86%;6个月随访率为88%,方案依从性接近100%。有效性的探索性分析表明,自我报告的依从性提高了7.3个百分点(95%CI:2.2,12.3);与SOC组相比,SYV组所有ART浓度值的合并标准差增加了0.17个单位(95%CI:-0.52,0.85)。基线时两组的病毒学抑制率(HIV RNA<400拷贝/mL)均为65%,但SYV组增加到75%,而SOC组保持不变(RR 1.13;95%CI:0.94,1.36)。
YPLWH的艾滋病毒治疗结果往往较差,因此针对该人群改善治疗结果的干预措施至关重要。这项基于坦桑尼亚的SYV干预试点试验表明,YPLWH在ART依从性和病毒学结果方面有改善趋势,支持将该干预措施扩大为全面的有效性试验的努力。
ClinicalTrials.gov标识符:NCT02888288。于2016年8月9日注册。追溯注册为2016年6月16日登记的第一名参与者。